Sangamo Therapeutics, Inc. Stock Price - SGMO

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 9.76 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Sangamo Therapeutics, Inc. SGMO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.45 4.83% 9.76 9.77 9.31 9.43 9.31 18:00:14
Bid Price Ask Price Spread Spread % News
9.25 9.85 0.60 6.09% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,821 1,577,200 $ 9.52 $ 15,019,232 1,914,491 6.26 - 19.25
Last Trade Time Type Quantity Stock Price Currency
17:21:25 99 $ 9.75 USD

Sangamo Therapeutics, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.13B 115.36M $ -68.33M -0.70 0.00 115.07M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.00 0.00% 119.25k 84.90%

more financials information »

Sangamo Therapeutics, Inc. News

Latest SGMO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SGMO Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week9.649.779.19.3882727k2M827k0.121.24%
1 Month10.0310.188.699.4225727k2M1M-0.27-2.69%
3 Months8.9914.798.6911.2616636k22M2M0.778.57%
6 Months11.4414.796.2610.5775636k22M2M-1.68-14.69%
1 Year15.519.256.2612.4964624k22M2M-5.74-37.03%
3 Years5.8727.52.6512.626284k22M2M3.8966.27%
5 Years16.6627.52.6511.96741022M1M-6.9-41.42%

Sangamo Therapeutics, Inc. Description

Sangamo BioSciences, Inc., is a clinical stage biopharmaceutical company engaged in the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs.

Your Recent History
Sangamo Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.